Market Overview:
The global food allergy diagnostics and therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of food allergies, rising awareness about food allergies, and technological advancements in the field of diagnostics. The global food allergy diagnostics and therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostic products, instruments, consumables, and services. The diagnostic products segment is further sub-segmented into tests kits & reagents and analyzers & readers. The instruments segment is further sub-segmented into chromatography systems & detectors; immunoassay analyzers; spectroscopy systems; molecular biology systems; centrifuges; electrophoresis systems; sample preparation equipment’s ;and others). The consumables segment is further sub-segmented into antibodies & antigens ;reagents ;cultures media ;and others). On the basis of application ,the marketis dividedinto academic research institutes hospitals& clinics ,diagnostic laboratories .
Product Definition:
Food allergy diagnostics and therapeutics are the methods and treatments used to diagnose and treat food allergies. Food allergies are a type of hypersensitivity reaction that occurs when the body mistakenly identifies a food as harmful. Symptoms of food allergies can range from mild, such as skin irritation, to life-threatening, such as anaphylaxis. The diagnosis of a food allergy is typically based on a patient's medical history and a physical examination. There is no single test that can definitively diagnose a food allergy; however, there are several tests that can help rule out other causes of the symptoms. Once a diagnosis has been made, treatment options include dietary changes, medications, or immunotherapy. Immunotherapy is often considered the best long-term treatment for severe cases of food allergies.
Diagnostic Products:
Diagnostic products, it's usage and growth factor in the food allergy diagnostics and therapeutics market: The global diagnostic products, it's usage and growth factor in the food allergy diagnostics market is expected to witness significant growth over the forecast period. Food allergies are serious health conditions that result due to harmful effects of certain foods on human body. These allergic reactions can range from simple itchiness, skin rashes to low blood pressure, diarrhea or even death.
Instruments:
Instruments and it's usage in food allergy diagnostics and therapeutics market is expected to witness lucrative growth over the forecast period owing to increasing incidences of food allergies among children. Food allergic reactions are caused by inappropriate immune responses which occur when the body reacts to certain foods containing allergens, usually proteins. The most common symptoms associated with this condition are itching, swelling of the tongue or throat, nausea or vomiting often followed by diarrhea.
Application Insights:
The academic research institutes segment held the largest market share in 2017. This is attributed to the presence of a large number of researchers working on various projects related to diagnosis and therapeutics for food allergies. Furthermore, this segment is expected to grow at a lucrative rate during the forecast period owing to increasing government funding for research in this field.
Food allergy diagnostics are gaining significant importance in clinical settings as they help identify patients with similar symptoms across different geographical locations and assist allergists/immunologists in making accurate diagnoses. As per estimates by EMA, over 100 million people globally suffer from food allergies annually, which accounts for about 0.5% - 1% of total population depending upon locale (source). Thus, rising prevalence coupled with demand from key applications such as hospitals & clinics is anticipated to boost product demand over the forecast period.
Global food allergy diagnostics.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high adoption rate for new technologies are some of the factors contributing to its growth. Furthermore, increasing prevalence of food allergies is also expected to drive regional growth over the forecast period. For instance, according to a study published by National Institute of Health (NIH), in U.S., around 8% population suffered from peanut allergy in 2014 whereas only 2% population had peanut allergy in 1997 [ ].
Asia Pacific region is anticipated to witness lucrative CAGR during the forecast period owing to rising disposable income and improving healthcare infrastructure especially in developing countries such as India and China [ ]. In addition, growing awareness about food allergies among people will propel market development further driving demand for diagnostic products used for testing allergic reactions caused by foods such as peanuts & tree nuts; seafood; eggs; milk; soybean & other legumes including peas & beans [ ].
Growth Factors:
- Increasing prevalence of food allergies: The global prevalence of food allergies is increasing at a significant rate. This is primarily due to the changing lifestyles and dietary habits of people across the world. According to a study by FAIR Health, the number of Americans with food allergies has increased by nearly 20% in just three years, from 2010 to 2013. The same study also found that the cost associated with treating food allergies has increased by more than 30%. This is indicative of the growing need for Food Allergy Diagnostics and Therapeutics products and services.
- Growing awareness about food allergies: There is a growing awareness among people about the symptoms and risks associated with food allergies. This has led to an increase in demand for Food Allergy Diagnostics and Therapeutics products and services worldwide. In addition, there is also a growing trend among consumers towards seeking out organic foods that are free from allergens such as peanuts, milk, eggs, etcetera .This further boosts demand for Food Allergy Diagnostics and Therapeutics products and services worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Food Allergy Diagnostics and Therapeutics Market Research Report
By Type
Diagnostic Products, Instruments, Consumables, Services
By Application
Academic Research Institutes, Hospitals & Clinics, Diagnostics Laboratories
By Companies
Allergy Therapeutics, Cambridge Allergy Ltd, Astellas Pharma, Inc., Immunomic Therapeutics, Inc., Prota Therapeutics Pty Ltd, Aimmune Therapeutics, Pfizer, ALK-Abello Ltd, Medeca Pharma AB, BioMerieux, Omega Diagnostics Group, HYCOR Biomedical, HOB Biotech Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Food Allergy Diagnostics and Therapeutics Market Report Segments:
The global Food Allergy Diagnostics and Therapeutics market is segmented on the basis of:
Types
Diagnostic Products, Instruments, Consumables, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research Institutes, Hospitals & Clinics, Diagnostics Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergy Therapeutics
- Cambridge Allergy Ltd
- Astellas Pharma, Inc.
- Immunomic Therapeutics, Inc.
- Prota Therapeutics Pty Ltd
- Aimmune Therapeutics
- Pfizer
- ALK-Abello Ltd
- Medeca Pharma AB
- BioMerieux
- Omega Diagnostics Group
- HYCOR Biomedical
- HOB Biotech Group
Highlights of The Food Allergy Diagnostics and Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Products
- Instruments
- Consumables
- Services
- By Application:
- Academic Research Institutes
- Hospitals & Clinics
- Diagnostics Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Food Allergy Diagnostics and Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Food allergy diagnostics and therapeutics is the study of how to diagnose and treat food allergies.
Some of the major companies in the food allergy diagnostics and therapeutics market are Allergy Therapeutics, Cambridge Allergy Ltd, Astellas Pharma, Inc., Immunomic Therapeutics, Inc., Prota Therapeutics Pty Ltd, Aimmune Therapeutics, Pfizer, ALK-Abello Ltd, Medeca Pharma AB, BioMerieux, Omega Diagnostics Group, HYCOR Biomedical, HOB Biotech Group.
The food allergy diagnostics and therapeutics market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Food Allergy Diagnostics and Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Food Allergy Diagnostics and Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Food Allergy Diagnostics and Therapeutics Market - Supply Chain
4.5. Global Food Allergy Diagnostics and Therapeutics Market Forecast
4.5.1. Food Allergy Diagnostics and Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Food Allergy Diagnostics and Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Food Allergy Diagnostics and Therapeutics Market Absolute $ Opportunity
5. Global Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
5.3.1. Diagnostic Products
5.3.2. Instruments
5.3.3. Consumables
5.3.4. Services
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
6.3.1. Academic Research Institutes
6.3.2. Hospitals & Clinics
6.3.3. Diagnostics Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Food Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
9. North America Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
9.4.1. Academic Research Institutes
9.4.2. Hospitals & Clinics
9.4.3. Diagnostics Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
9.7.1. Diagnostic Products
9.7.2. Instruments
9.7.3. Consumables
9.7.4. Services
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Food Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
10.4.1. Academic Research Institutes
10.4.2. Hospitals & Clinics
10.4.3. Diagnostics Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
10.7.1. Diagnostic Products
10.7.2. Instruments
10.7.3. Consumables
10.7.4. Services
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Food Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
11. Europe Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
11.4.1. Academic Research Institutes
11.4.2. Hospitals & Clinics
11.4.3. Diagnostics Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
11.7.1. Diagnostic Products
11.7.2. Instruments
11.7.3. Consumables
11.7.4. Services
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Food Allergy Diagnostics and Therapeutics Demand Share, 2019-2026
12. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
12.4.1. Academic Research Institutes
12.4.2. Hospitals & Clinics
12.4.3. Diagnostics Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
12.7.1. Diagnostic Products
12.7.2. Instruments
12.7.3. Consumables
12.7.4. Services
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Food Allergy Diagnostics and Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Food Allergy Diagnostics and Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Application
13.4.1. Academic Research Institutes
13.4.2. Hospitals & Clinics
13.4.3. Diagnostics Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Food Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Type
13.7.1. Diagnostic Products
13.7.2. Instruments
13.7.3. Consumables
13.7.4. Services
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Food Allergy Diagnostics and Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Food Allergy Diagnostics and Therapeutics Market: Market Share Analysis
14.2. Food Allergy Diagnostics and Therapeutics Distributors and Customers
14.3. Food Allergy Diagnostics and Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergy Therapeutics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cambridge Allergy Ltd
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Astellas Pharma, Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Immunomic Therapeutics, Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Prota Therapeutics Pty Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aimmune Therapeutics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ALK-Abello Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medeca Pharma AB
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. BioMerieux
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Omega Diagnostics Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. HYCOR Biomedical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. HOB Biotech Group
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
